$0.6982
-0.04-5.65%
At close: -
$0.7331
0.035.00%
After Hours: 7:59 PM EDT
Comments
Loading...
Ovid Therapeutics (NASDAQ:OVID) Stock, Earnings Estimates, EPS, And Revenue
Ovid Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 7
EPS Estimate
$-0.180
Quarterly Revenue Estimate
$100.00K
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$631.70K
Analyze the earnings history of Ovid Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Ovid Therapeutics (OVID) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-12 | $-0.20 | $-0.19 | -5.26 % |
| Q2 | 2024-08-13 | $0.12 | $-0.22 | 154.6 % |
| Q1 | 2024-05-14 | $-0.17 | $-0.22 | 22.7 % |
| Q4 | 2024-03-08 | $-0.22 | $-0.05 | -340.0 % |
Ovid Therapeutics (OVID) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-12 | $173.00K | $87.14K | 98.5 % |
| Q2 | 2024-08-13 | $169.00K | $70.00K | 141.4 % |
| Q1 | 2024-05-14 | $148.00K | $60.00K | 146.7 % |
| Q3 | 2023-11-03 | $108.97K | $50.00K | 117.9 % |
FAQ
When is Ovid Therapeutics (NASDAQ:OVID) reporting earnings?
Ovid Therapeutics (OVID) is scheduled to report earnings on March 7, 2025. The last reported earnings were for reported on November 12, 2024 for Q3.
What were the latest earnings per share (EPS) for Ovid Therapeutics (NASDAQ:OVID)?
The Actual EPS was $-0.20, which missed the estimate of $-0.19.
What were Ovid Therapeutics’s (NASDAQ:OVID) revenues?
The Actual Revenue was $173K, which beat the estimate of $87.1K.
Browse earnings estimates, EPS, and revenue on all stocks.